After losing 27% in the past year, Cytek Biosciences, Inc. (NASDAQ:CTKB) institutional owners must be relieved by the recent gain [Yahoo! Finance]
Cytek Biosciences, Inc. (CTKB)
Company Research
Source: Yahoo! Finance
The top 8 shareholders own 54% of the company Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock If you want to know who really controls Cytek Biosciences, Inc. ( NASDAQ:CTKB ), then you'll have to look at the makeup of its share registry. The group holding the most number of shares in the company, around 58% to be precise, is institutions. In other words, the group stands to gain the most (or lose the most) from their investment into the company. Last week's US$95m market cap gain would probably be appreciated by institutional investors, especially after a year of 27% losses. In the chart below, we zoom in on the different ownership groups of Cytek Biosciences. View our latest analysis for Cytek Biosciences What Does The Institutional Ownership Tell Us About Cytek Biosciences? Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention
Show less
Read more
Impact Snapshot
Event Time:
CTKB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTKB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTKB alerts
High impacting Cytek Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
CTKB
News
- Cytek Biosciences, Inc. (CTKB) Stock Moves -0.33%: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe [Yahoo! Finance]Yahoo! Finance
- Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and EuropeGlobeNewswire
- Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024GlobeNewswire
- Cytek Biosciences (CTKB) Is Considered a Good Investment by Brokers: Is That True? [Yahoo! Finance]Yahoo! Finance
CTKB
Earnings
- 11/7/23 - Miss
CTKB
Sec Filings
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- 4/25/24 - Form DEF
- CTKB's page on the SEC website